NRC HEALTH
NRC · XNASCIK 70487fmd_161AD799KM2B46Z3VWCD19M7RWServices · Services-Commercial Physical & Biological ResearchTemplate: Standard
Coverage: Jan 01, 2009 to Sep 30, 2026, 67 periods
| Line item | FY2016 | FY2017 | FY2018 | FY2019 | FY2020 | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|---|---|---|---|---|
| Total revenues | 109 | 118 | 120 | 128 | 133 | 148 | 152 | 149 | 143 | 137 |
| Selling, general and administrative | 28 | 30 | 31 | 33 | 34 | 39 | 43 | 47 | 45 | 55 |
| Total operating expenses | 78 | 83 | 84 | – | – | – | – | – | – | – |
| Operating income | 31 | 34 | 35 | 43 | 43 | 50 | 47 | 40 | 35 | 23 |
| Interest expense | 0 | 0 | 2 | 2 | 2 | 2 | 1 | 1 | 3 | 5 |
| Interest and investment income | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1 | 0 | 0 |
| Other non-operating income (expense) | 0 | 0 | (1) | (3) | (1) | (2) | (4) | (0) | (3) | (5) |
| Income before taxes | 31 | 34 | 35 | 41 | 41 | 49 | 43 | 40 | 33 | 18 |
| Income tax expense | 11 | 11 | 5 | 8 | 4 | 11 | 11 | 9 | 8 | 6 |
| Net income from continuing operations | 21 | 23 | 30 | 32 | 37 | 37 | 32 | 31 | 25 | 12 |
| Net income | 21 | 23 | 30 | 32 | 37 | 37 | 32 | 31 | 25 | 12 |
| Net income to common shareholders | – | – | – | – | 37 | 37 | 32 | 31 | 25 | 11 |